Seminars in Hematology
Volume 47, Issue 1 , Pages 97-103 , January 2010

Umbilical Cord Transplantation: Epilogue

  • Hal E. Broxmeyer

      Affiliations

    • Corresponding Author InformationAddress correspondence to Hal E. Broxmeyer, PhD, Department of Microbiology and Immunology, Indiana University School of Medicine, 950 W Walnut St, R2 Building, Room 302, Indianapolis, IN 46202-5181

References 

  1. Broxmeyer HE. Cord blood transplantation: a mini review celebrating the 20th anniversary of the first cord blood transplant. Hematologist. 2009;6:7
  2. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989;86:3828–3832
  3. Broxmeyer HE, Kurtzberg J, Gluckman E, Auerbach AD, Douglas G, Cooper S, et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells. 1991;17:313–329
  4. Gluckman E, Broxmeyer HE, Auerbach AD, Friedman H, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–1178
  5. Broxmeyer HE. Introduction: Past, present and future of cord blood transplantation. In:  Broxmeyer HE editors. Cellular characteristics of cord blood and cord blood transplantation. Bethesda, MD: American Association of Blood Banking; 1997;p. 1–11
  6. Broxmeyer HE. Introduction (Cord blood transplantation: looking back and to the future). In:  Cohen SBA,  Gluckman E,  Rubinstein P,  Madrigal JA editor. Cord blood characteristics: role in stem cell transplantation. London: Dunitz; 2000;p. 1–12
  7. Broxmeyer HE, Smith FO. Cord blood hematopoietic cell transplantation. In:  Appelbaum FR,  Forman SJ,  Negrin RS,  Blume KG editor. Thomas' hematopoietic cell transplantation. 4th ed.. West Sussex, UK: Wiley-Blackwell; 2009;p. 559–576
  8. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang M-J, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–2275
  9. Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D, et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008;112:4318–4327
  10. Sauter C, Barker JN. Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies. Curr Opin Hematol. 2008;15:568–575
  11. Advani AS, Laughlin MJ. Umbilical cord blood transplantation for acute myeloid leukemia. Curr Opin Hematol. 2009;16:124–128
  12. Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood. 2009;113:1631–1638
  13. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J, et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant. 2007;13:1073–1082
  14. Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y, et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant. 2008;14:1057–1063
  15. Parikh SH, Mendizabal A, Martin PL, Prasad VK, Szabolcs P, Driscoll TA, et al. Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience. Biol Blood Marrow Transplant. 2009;15:948–955
  16. Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112:2979–2989
  17. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 deaths with hematologic disease. Blood. 2007;110:3064–3070
  18. Uchida T, Wake A, Takagi S, Yamamoto H, Kato D, Matsubashi Y, et al. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biol Blood Marrow Transplant. 2008;14:583–590
  19. Brunstein CG, Wagner JE. Umbilical cord blood transplantation. In:  Hoffman R,  Benz EJ,  Shattil SJ,  Furie B,  Silberstein LE,  McGlave P,  Heslop H,  Anastasi J editor. Hematology: basic principles and practice. 5th ed.. Philadelphia: Elsevier Churchill Livingston; 2009;p. 1643–1664
  20. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol. 2007;137:20–35
  21. Fernandes J, Rocha V, Robin M, Peffault de Latour R, Traineau R, Devergie A, et al. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol. 2007;137:248–251
  22. Hayani A, Lampeter E, Viswanatha D, Morgan D, Salvi SN. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics. 2007;119:e296–e300
  23. Nietfeld JJ, Marcelo C, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S.. Biol Blood Marrow Transplant. 2008;14:316–322
  24. Majeti R, Park CY, Weissman IL. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell. 2007;1:635–645
  25. Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood. 112:3543-53.
  26. Tao W, Broxmeyer HE. Towards a molecular understanding of hematopoietic stem and progenitor cells. In:  Broxmeyer HE editors. Cord blood: biology, immunology, banking, and clinical transplantation. Bethesda, MD: American Association of Blood Banking; 2004;p. 87–123
  27. Tao W, Wang M, Voss ED, Cocklin RR, Smith J, Cooper S, et al. Comparative proteomic analysis of human CD34+ stem/progenitor cells and mature CD15+ myeloid cells. Stem Cells. 2004;22:1003–1014
  28. Wu M, Kwon HY, Rattis F, Blum J, Zhao C, Ashkenazi R, et al. Imaging hematopoietic precursor division in real time. Cell Stem Cell. 2007;1:541–554
  29. Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell. 2008;132:487–498
  30. Yashiro Y, Bannai H, Minowa T, Yabiku T, Miyano S, Osawa M, et al. Transcriptional profiling of hematopoietic stem cells by high-throughput sequencing. Int J Hematol. 2009;89:24–33
  31. Hills M, Lucke K, Chavez EA, Eaves CJ, Lansdorp PM. Probing the mitotic history and development of hematopoietic cells using single telomere length analysis (STELA). Blood. 113:5765-75.
  32. Yamazaki S, Nakauchi H. Insights into signaling and function of hematopoietic stem cells at the single level. Curr Opin Hematol. 2009;16:255–258
  33. Beckmann J, Scheitza S, Wernet P, Fischer JC, Giebel B. Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins. Blood. 2007;109:5494–5501
  34. Mantel CR, Wang R-H, Deng C, Broxmeyer HE. Sirt1, Notch, and stem cell “age asymmetry”. Cell Cycle. 2008;7:2821–2825
  35. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson JA, Bodine D. High efficiency recovery of hematopoietic progenitor cells with extensive proliferative and ex-vivo expansion activity and of hematopoietic stem cells with NOD/SCID mouse repopulation ability from human cord blood stored frozen for 15 years. Proc Natl Acad Sci U S A. 2003;100:645–650
  36. Bornstein R, Flores AI, Montalban MA, Del Rey JJ, De La Serna J, Gilsanz F. A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients. Stem Cells. 2005;23:324–334
  37. Broxmeyer HE, Cooper S, Hass DM, Hathaway JK, Stehman FB, Hangoc G. Experimental basis of cord blood transplantation. Bone Marrow Transplant. 2009;e-pub ahead of print
  38. Gekas C, Dieterlen-Lievre F, Orkin SH, Mikkola HK. The placenta is a niche for hematopoietic stem cells. Dev Cell. 2005;8:365–375
  39. Mikkola HKA, Gekas C, Orkin SH, Dieterlen-Lievre F. Placenta as a site for hematopoietic stem cell development. Exp Hematol. 2005;33:1048–1054
  40. Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol. 7:333-7.
  41. Spiegel A, Kalinkovich A, Shivtiel S, Kollet O, Lapidot T. Stem cell regulation via dynamic interactions of the nervous and immune systems with the microenvironment. Cell Stem Cell. 2008;3:484–492
  42. Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008;132:598–611
  43. Christopherson KW, Hangoc G, Mantel C, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science. 2004;305:1000–1003
  44. Campbell TB, Hangoc G, Liu Y, Pollok K, Broxmeyer HE. Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev. 2007;16:347–354
  45. Tian C, Bagley J, Forman D, Iacomini J. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther. 13:652-8.
  46. Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood. 108:4268-74.
  47. Christopherson KW, Paganessi LA, Napier S, Porecha NK. CD26 inhibition on CD34+ or lineage- human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/Beta2null immunodeficient mice. Stem Cells Dev. 2007;16:355–360
  48. Kawai T, Choi U, Liu PC, Whiting-Theobald NL, Linton GF, Malech HL. Diprotin A infusion into nonobese diabetic/severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells. Stem Cells Dev. 2007;16:361–370
  49. Wyss BK, Donnelly AFW, Zhou D, Sinn AL, Pollok K, Goebel WS. Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by diprotin A. Exp Hematol. 2009;37:814–823
  50. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature. 2007;447:1007–1011
  51. Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 2009;113:5444–5455
  52. Broxmeyer HE. Mechanism unknown: prostaglandin E2 may improve HSC therapies. Cell Stem Cell. 2007;1:135–136
  53. Xia L, McDaniel JM, Yago T, Doeden A, McEver RP. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood. 2004;104:3091–3096
  54. Adams GB, Alley IR, Chung U-I, Chabner KT, Jeanson NT, Lo Celso C, et al. Haematopoietic stem cells depend on Gαs-mediated signaling to engraft bone marrow. Nature. 2009;459:103–108
  55. Kimura T, Asada R, Wang J, Kimura T, Morioka M, Matsui K, et al. Identification of long-term repopulating potential of human cord blood-derived CD34−flt3− severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells. 2007;25:1348–1355
  56. Inaba M, Adachi Y, Hisha H, Hosaka N, Maki M, Ueda Y, et al. Extensive studies on perfusion method plus intra-bone marrow-bone marrow transplantation using cynomolgus monkeys. Stem Cells. 2007;25:2098–2103
  57. Jung WC, Beard BC, Morris JC, Neff T, Beebe K, Storer BE, et al. Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primates. Exp Hematol. 2007;35:1132–1139
  58. Shaheen M, Broxmeyer HE. The humoral regulation of hematopoiesis. In:  Hoffman R,  Benz EJ,  Shattil SJ,  Furie B,  Silberstein LE,  McGlave P,  Heslop H,  Anastasi J editor. Hematology: basic principles and practice. 5th ed.. Philadelphia: Elsevier Churchill Livingston; 2009;p. 253–275
  59. Dahl R, Hromas R. Transcriptional factors in normal and malignant hematopoiesis. In:  Hoffman R,  Benz EJ,  Shattil SJ,  Furie B,  Silberstein LE,  McGlave P,  Heslop H,  Anastasi J editor. Hematology: basic principles and practice. 5th ed.. Philadelphia: Elsevier Churchill Livingston; 2009;p. 213–230
  60. Finkel T, Deng C-X, Mostoslavsky R. Recent progress in the biology and physiology of Sirtuins. Nature. 2009;460:587–591
  61. Han M-K, Song EK, Guo Y, Ou X, Mantel C, Broxmeyer HE. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell. 2008;2:241–251
  62. Campbell TB, Basu S, Hangoc G, Tao G, Broxmeyer HE. Overexpression of the novel ras related GTPase Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing in vivo stem cell repopulation. Blood. 2009;114:3392–3401
  63. Bianco R, Gehron Robey P, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2:313–319
  64. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature. 2008;8:726–736
  65. Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther. 2009;17:939–946
  66. Broxmeyer HE, Srour E, Orschell C, Ingram DA, Cooper S, Plett PA, et al. Cord blood hematopoietic stem and progenitor cells (In: Klimanskaya I, Lanza R, editors). Methods Enzymol. 2009;419:439–473
  67. Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood. 2008;111:1302–1305
  68. Yoder MC, Ingram DA. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol. 2009;16:269–273
  69. Mund JA, Ingram DA, Yoder MC, Case J. Endothelial progenitor cells and cardiovascular cell-based therapies. Cytotherapy. 2009;11:103–113
  70. Giarratana M-C, Kobari L, Lapillonne H, Chalmers D, Kiger L, Cynober T, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotech. 2005;23:69–74
  71. Migliaccio AR, Whitsett C, Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol. 2009;16:259–268
  72. Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan JH, et al. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture. Exp Hematol. 2008;36:244–252
  73. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676
  74. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–317
  75. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluirpotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–1920
  76. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from human fibroblasts by defined factors. Cell. 2007;131:861–872
  77. Loh Y-H, Agarwal S, Park I-H, Urbach A, Huo H, Heffner GC, et al. Generation of induced pluripotent stem cells from human blood. Blood. 2009;113:5476–5479
  78. Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C, et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell. 2009;5:434–441
  79. Ye Z, Zhang H, Mali P, Dowey S, Williams DM, Jang Y-Y, et al. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009;e-pub ahead of print
  80. Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodriguez-Piza I, Vassena R, et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell. 2009;5:353–357
  81. Park I-H, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell. 2008;134:877–886
  82. Hanna J, Wernig M, Markoulaki S, Sun C-W, Meissner A, Cassady JP, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007;318:1920–1923
  83. Yamanaka S. A fresh look at iPS cells. Cell. 2009;137:13–17

 Some studies referred to in this article from the author's laboratory were supported by US Public Service Health Awards No. R01HL5646 and R01HL67384, and a Project in P01HL67384 from the National Institutes of Health to H.E.B.

PII: S0037-1963(09)00133-4

doi: 10.1053/j.seminhematol.2009.10.002

Seminars in Hematology
Volume 47, Issue 1 , Pages 97-103 , January 2010

Article Tools